BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1668901)

  • 1. Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
    Sárosi I; Kiss A; Schaff Z; Lapis K
    Acta Morphol Hung; 1991; 39(4):321-31. PubMed ID: 1668901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue content of fibrolamellar carcinoma and other human liver tumors.
    Sárosi I; Kiss A; Schaff Z; Lapis K
    Acta Microbiol Hung; 1991; 39(4):321-31. PubMed ID: 1668900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    El-Serag HB; Davila JA
    Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A particular hepatocellular carcinoma combining the ordinary and the fibrolamellar variant].
    Zermani R; Charfi L; Kourda N; Farah F; Rammeh S; Trabelsi O; Zaouch A; Ben Jilani S
    Tunis Med; 2005 Jul; 83(7):419-21. PubMed ID: 16220700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatocellular adenoma and focal nodular hyperplasia].
    Mangiante G; Pistacchi E; Marchiori L; Nicoli N; Dagradi A
    Chir Ital; 1989; 41(2-3):117-28. PubMed ID: 2561631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrolamellar carcinoma of the liver: CT, ultrasound and angiography. Case report.
    Bedi DG; Kumar R; Morettin LB; Gourley K
    Eur J Radiol; 1988 May; 8(2):109-12. PubMed ID: 2838279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrolamellar hepatocellular carcinoma arising in a background of focal nodular hyperplasia: a report of 2 cases.
    Imkie M; Myers SA; Li Y; Fan F; Bennett TL; Forster J; Tawfik O
    J Reprod Med; 2005 Aug; 50(8):633-7. PubMed ID: 16220774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor beta 1 in human liver tumors.
    Vogelbruch M; Wellmann A; Maschek H; Schäfer MK; Flemming P; Georgii A
    Verh Dtsch Ges Pathol; 1995; 79():132-6. PubMed ID: 8600677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of xenobiotic and steroid hormone metabolizing enzymes in hepatocellular tumors of the non-cirrhotic liver.
    Haas S; Merkelbach-Bruse S; Justenhoven C; Brauch H; Fischer HP
    Pathol Res Pract; 2009; 205(10):716-25. PubMed ID: 19596526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
    Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
    Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrolamellar carcinoma of the liver.
    Yamaguchi R; Tajika T; Kanda H; Nakanishi K; Kawanishi J
    Hepatogastroenterology; 1999; 46(27):1706-9. PubMed ID: 10430327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Focal nodular hyperplasia and liver cell adenoma: operation or observation?].
    Ott R; Hohenberger W
    Zentralbl Chir; 1998; 123(2):145-53. PubMed ID: 9556887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrolamellar carcinoma of the liver: a distinct entity within the hepatocellular tumors. A review.
    Vecchio FM
    Appl Pathol; 1988; 6(2):139-48. PubMed ID: 2839216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report.
    Okano A; Hajiro K; Takakuwa H; Kobashi Y
    Am J Gastroenterol; 1998 Jul; 93(7):1144-5. PubMed ID: 9672347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric analysis of DNA content in focal nodular hyperplasia and hepatocellular carcinoma.
    Kopper L; Lapis K; Schaff Z; Mihalik R; Karácsony S; Szécsény A
    Neoplasma; 1991; 38(3):257-63. PubMed ID: 1649974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathobiology of human primary benign and malignant liver tumors].
    Schaff Z; Jeney A; Kopper L; Kovalszky I; Karácsonyi S; Szécsény A; Lapis K
    Morphol Igazsagugyi Orv Sz; 1990 Jan; 30(1):18-27. PubMed ID: 2407943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization. Synchronous occurrence of focal nodular hyperplasia and hepatocellular carcinoma in the same liver is not based on common chromosomal aberrations.
    Kellner U; Jacobsen A; Kellner A; Mantke R; Roessner A; Röcken C
    Am J Clin Pathol; 2003 Feb; 119(2):265-71. PubMed ID: 12579998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical study of HBV antigens in 338 liver cell carcinomas.
    Herrmann G
    Z Gastroenterol; 1999 May; 37(5):329-42. PubMed ID: 10413841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia.
    Paradis V; Bièche I; Dargère D; Laurendeau I; Nectoux J; Degott C; Belghiti J; Vidaud M; Bedossa P
    Gastroenterology; 2003 Mar; 124(3):651-9. PubMed ID: 12612904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.